AMGEN Inc

NASDAQ: AMGN
$270.00
+$3.55 (+1.3%)
Closing price April 11, 2024
Amgen Inc. is a biotechnology pioneer focused on developing and delivering innovative human therapeutics. Its portfolio includes treatments for serious illnesses such as rheumatoid arthritis, psoriasis, osteoporosis, and various types of cancer. Among its well-known products are Enbrel, Otezla, Prolia, and Repatha. Amgen also collaborates with other pharmaceutical giants to enhance its product offerings, demonstrating a commitment to improving patient health globally. Founded in 1980, Amgen has grown to serve healthcare providers and patients worldwide from its headquarters in Thousand Oaks, California.
The Artificial Intelligence rally over the last year, led by the so-called “Magnificent 7,” has been fantastic if you owned those stocks. However, most of the S&P 500 is treading water and...
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
Here are some of the top upgrades, downgrades and other analyst calls for Thursday, December 21, along with other investing news.
Tuesday's most notable analyst upgrades and downgrades and other calls were on Amazon, PepsiCo, Netflix and more.
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
After years of a low-interest rate environment, which has reversed in a big way over the last 18 months, many investors continue to turn to equities not only for growth potential but also for solid...
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and...
Thursday's top analyst upgrades and downgrades included Amgen, Arista Networks, Boeing, Coherent, CSX, Netflix, Northrop Grumman, Shoals Technologies, Take-Two Interactive Software, Unilever and...
Tuesday's top analyst upgrades and downgrades included Airbnb, Amgen, Aramark, Arm, Datadog, Delta Air Lines, Match, Oracle, Patterson-UTI Energy, PayPal, Spotify Technology, Unity Software and...
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Thursday's top analyst upgrades and downgrades included American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines, Taiwan Semiconductor Manufacturing and Toast.
Thursday's top analyst upgrades and downgrades included Amazon.com, American Electric Power, Amgen, BHP, Duke Energy, General Mills, KeyCorp, Lowe's Companies, Macy's, Marvell Technology, Netflix,...
Tuesday's top analyst upgrades and downgrades included Amgen, CF Industries, Coterra Energy, CymaBay Therapeutics, Eaton, Marriott, Monster Beverage, Mosaic, Nutrien, Public Service Enterprise, Urban...
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange,...
The highest-yielding stocks in the Nasdaq offer a contrarian angle for the rest of 2023. They all have some solid defensive qualities, and they are offering among the best entry points seen in some...